INMD INMD
Company Profile ↓Company Overview
INMD (INMD) is a publicly traded company listed on with a market capitalization of $1.34B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 10.6.
Maintains a net profit margin of 25.3%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $370.50M (-6.2% YoY); net profit $93.83M.
- Trailing 12 Months Year-on-year growth — revenue -6.2%, earnings -48.2%.
- 5-Year Trend Long-term compounding — revenue CAGR -6.6%, profit CAGR -16.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -6.57% |
| 1 Year: | -6.16% |
Compounded Profit Growth
| 5 Years: | -16.56% |
| 1 Year: | -48.24% |
Stock Price Performance
| 1 Year: | +8.10% |
| 6 Months: | -4.34% |
| 3 Months: | +5.63% |
| 1 Month: | +4.61% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross4d ago
- RSI (14)55.07 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 25.3%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -6.6% CAGR over 5 years.
- Earnings shrank at -16.6% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 77.87M | 95.60M | 93.17M | 103.85M | 82.02M |
| Cost of Revenue | 16.96M | 19.15M | 20.86M | 22.55M | 20.46M |
| Gross Profit | 60.91M | 76.45M | 72.31M | 81.30M | 61.55M |
| Operating Expenses | 45.29M | 53.57M | 51.41M | 55.31M | 51.50M |
| Operating Income | 15.62M | 22.88M | 20.90M | 25.99M | 10.06M |
| EBITDA | 15.79M | 23.07M | 21.05M | 26.16M | 10.23M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | 22.48M | 30.94M | 25.62M | 31.29M | 14.35M |
| Tax Provision | 4.28M | 4.20M | 3.75M | 4.27M | 2.79M |
| Net Income | 18.20M | 26.74M | 21.86M | 27.02M | 11.56M |
| Diluted EPS | 0.26 | 0.42 | 0.34 | 0.42 | 0.18 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 454.27M | 492.05M | 394.82M | 370.50M |
| Cost of Revenue | - | 73.48M | 80.71M | 77.75M | 79.53M |
| Gross Profit | - | 380.79M | 411.34M | 317.07M | 290.97M |
| Operating Expenses | - | 182.93M | 215.68M | 204.53M | 205.58M |
| Operating Income | - | 197.85M | 195.66M | 112.53M | 85.39M |
| EBITDA | - | 198.53M | 196.28M | 113.26M | 86.08M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | - | 201.47M | 217.27M | 143.47M | 110.33M |
| Tax Provision | - | 39.95M | 19.35M | -37.81M | 16.50M |
| Net Income | - | 161.52M | 197.92M | 181.28M | 93.83M |
| Diluted EPS | - | 1.89 | 2.30 | 2.25 | 1.43 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 644.41M | 863.29M | 785.67M | 766.43M |
| Current Assets | - | 629.37M | 845.33M | 714.45M | 698.62M |
| Cash & Equivalents | - | 97.54M | 144.41M | 155.33M | 302.54M |
| Inventory | - | 39.90M | 45.09M | 59.55M | 74.05M |
| Receivables | - | 27.00M | 42.36M | 36.34M | 43.50M |
| Total Liabilities | - | 89.79M | 75.91M | 81.85M | 83.23M |
| Current Liabilities | - | 82.02M | 64.14M | 69.85M | 70.74M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 4.96M | 9.02M | 7.82M | 8.23M |
| Total Equity | - | 554.62M | 787.37M | 703.81M | 683.20M |
| Shares Outstanding | - | 84.52M | 85.96M | 87.58M | 88.33M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 181.58M | 176.83M | 132.66M | 85.26M |
| Investing Cash Flow | - | -109.47M | -136.06M | 162.21M | 186.03M |
| Financing Cash Flow | - | -41.09M | 5.50M | -282.77M | -126.06M |
| Capital Expenditure | - | -1.57M | -705.00K | -669.00K | -972.00K |
| Free Cash Flow | - | 180.00M | 176.12M | 132.00M | 84.28M |
| Net Change in Cash | - | 31.02M | 46.27M | 12.10M | 145.23M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 83.8% | 83.6% | 80.3% | 78.5% |
| Operating Margin % | - | 43.6% | 39.8% | 28.5% | 23.0% |
| Net Margin % | - | 35.6% | 40.2% | 45.9% | 25.3% |
| ROE % | - | 29.1% | 25.1% | 25.8% | 13.7% |
| ROCE % | - | 35.2% | 24.5% | 15.7% | 12.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for INMD
InMode Completes $87.8M Share Buyback; Cash Totals $501.1M - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNbHItWVh1elJVcmFDb3p3VWVZRmtZZWg4N0xraHVEOG9ZTTlRY0RDUXdPRWJXcGVnd2htdWk0UVNrTFkzLVNrR1BGc3JneDk4VTltTjVUMkcwS0w2UUUtMzg4dGRwWV9fS0RpR1BfQ0ZYRG9LTnYxVUV5azlyNWFBYzE0NERXcnFSbjVnVk…
InMode Shares Jump After Steel Partners Tables Higher Takeover Proposal (INMD) - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQd3V3a3piSWNNbUdFekJIOF9TNjNGczMyelV2VmFqZThBZHV2bUxTYmJzQ3pZRklxYnVub3U5RHNWMjJXRS1yVlhpRXNTMnJkOHVKZGFNUm91SlJUek90emtYdGtXS1NXNmR2SHJXWTNYY2VvY0xvb0c0TW1YT21HdnlROWRuNDNtRTEzd1…
INMD Stock Jumped Nearly 13% Today – What’s Powering The Rally? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPam9GNjBvMHJlbkdGUVhfY0QzQW1Jd1lGOWR5M3h3WDdIaDF0dDZ1NFBNTWVWdmlXODFaWE9BbndSQi1OZHluYlVxcWZJS0Nsbk14akN6cUU2bmo1Y3FXTzQtOWRIaU5ON0F3cFdndVAyMDhyVUM2bkd5RlRWVDlHWnRtbTNLS3RWQWhBY0…
InMode: The Beauty Of A Value Trap (NASDAQ:INMD) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTFBOZUpOUHVUUllOWjNBeVdXQVAxdkhTODUxSmpNaFIwclVoQTQ5YVMtSi1SODVucEZPLWpWWHdyR2VBM000Skd2QjJSZHVvNWpXZ255TW96TkxsV1FEQ3h3Smp4RTFoZUM4alc5aU1tVGdsX0tocFBwdzBrNnk3TVk?oc=5" target="_bla…
InMode (NASDAQ: INMD) investors back all four AGM proposals - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxONll0V3cwX3V5czh3cTl2VGxkV2F6dlRVRDQ5WlE4dlVlbmVaMENRODVoUzdaMm56UHU5bURoT0RDNEh5OUNfalFEQlZqSVdfekpWUmFNa3lzTm1rZGw4bmhZc0pWakYtYUdCbGFEOGU2RjU5NXdwcXo3T3oweWdOVDVueERsenlzd1Q1V3…
Responsive Playbooks and the INMD Inflection - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNV09DaVpfN1BuSjk1U1FnY2lhZmw2dlZway1XLW0wWlI0QXRMbVZ6c016c2V6SVh6TmhxM29QWlFrZW1FUTlxc2JxMVlJLW9ZdjNZQmh3WGppUmhrZm9LWjFwcFRyQ3JIMUYzNUhrV19jS1MwRFVFN0tMaGR6bXhQUVJkZ2pNWXJDUXVjQj…
INMD — Frequently Asked Questions
What is the current share price of INMD?
As of 2026-08-05 17:25 PDT, INMD trades at $15.21 on NASDAQ/NYSE. Its 52-week range is $12.76 to $16.62.
What is the market capitalisation of INMD?
INMD has a market capitalisation of $1.34B on NASDAQ/NYSE.
What is the P/E ratio of INMD?
INMD trades at a trailing price-to-earnings (P/E) ratio of 10.64. Its price-to-book (P/B) ratio is 1.97.
What is the return on equity (ROE) of INMD?
INMD has a return on equity (ROE) of 13.73%. Its return on capital employed (ROCE) is 12.27%.
Is INMD a good stock to buy?
This page provides a data-driven analysis of INMD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.